SCHEMBL5139716

SCHEMBL5139716

CCC[C@H](NC(=O)Cc1cccc(Oc2ccccc2)c1)C(=O)OC

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
POLB P06746 3/20 0.51
PTGES O14684 1/20 0.49
MME P08473 1/20 0.48
ACE P12821 1/20 0.48
CPA1 P15085 1/20 0.48
ACE2 Q9BYF1 1/20 0.48
CNR2 P34972 2/20 0.47
PSMB5 P28074 2/20 0.45
EPOR P19235 1/20 0.45
FFAR1 O14842 2/20 0.45
CTSD P07339 1/20 0.45
CCR8 P51685 1/20 0.45
CETP P11597 1/20 0.45
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21964974 0.92 ALDH1A1 (0.51) ALDH1A1LMNASMN1; SMN2POLBPTGES
SCHEMBL3902883 0.90 MME (0.56) ALDH1A1LMNASMN1; SMN2POLBPTGES
SCHEMBL6468835 0.82 MME (0.48) ALDH1A1LMNASMN1; SMN2POLBPTGES
SCHEMBL4064892 0.81 CTBP2 (0.54) ALDH1A1POLB
SCHEMBL5967075 0.79 POLB (0.59) ALDH1A1POLBCNR2PSMB5CTSS
SCHEMBL27510864 0.79 POLB (0.59) ALDH1A1POLBCNR2PSMB5CTSS
SCHEMBL7097974 0.78 POLB (0.52) ALDH1A1LMNAPOLBCNR2PSMB5
SCHEMBL8351647 0.77 FFAR1 (0.60) ALDH1A1POLBPTGESFFAR1CCR8
SCHEMBL6469284 0.77 GAA (0.47) ALDH1A1LMNASMN1; SMN2MMEACE
SCHEMBL6469018 0.77 FAAH (0.47) ALDH1A1LMNASMN1; SMN2PTGESMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654260-A4 6-MENBERED HETEROARYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PROD INC (US) 2008-09-24 EP disclosed
EP-1654260-A2 6-MENBERED HETEROARYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Pfizer Products Inc. (US) 2006-05-10 EP disclosed
WO-2005011601-A2 6-MENBERED HETEROARYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PRODUCTS, INC. (US) 2005-02-10 WO disclosed